Giles Gwinnett is a qualified journalist and has been a reporter for a number of regional newspapers and for a press agency. He was formerly a news analyst on the German team at Thomson Financial, now Thomson Reuters. He has a bachelor’s degree in English Literature and German and a master's in Film Studies.
Life sciences firm ValiRx is poised for a busy year ahead as it progresses its lead drugs...
Breedon Group supplies construction materials and has now expanded its geographical footprint
The bank, has had to draw up a new capital plan and bolster its balance sheet by £2bn.
The firm said this supported its planned production levels of up to 10,000 metric ton units of tungsten per month.
Bluebird Merchant Ventures revealed it had bought the rest of the Batangas gold project in the Philippines.
The suspension is pending an announcement regarding the results of the scoping study.
Six directors have bought shares in the AIM listed biotech
The broker notes that with US$60mln of investments planned over the next three years, production should grow at Kagemand double at Montepuez
A look at some analyst views from around the City on Friday
A look at some analyst takes on a variety of stocks on Thursday
It is doubtful of a pick-up next year though suggests Cobham as a potential recovery play if new management’s plan is appreciated by investors.
A look at some analyst views as the week begins